CA2507414A1 - Propargyl-trifluoromethoxy-amino-benzothiazole derivatives - Google Patents
Propargyl-trifluoromethoxy-amino-benzothiazole derivatives Download PDFInfo
- Publication number
- CA2507414A1 CA2507414A1 CA002507414A CA2507414A CA2507414A1 CA 2507414 A1 CA2507414 A1 CA 2507414A1 CA 002507414 A CA002507414 A CA 002507414A CA 2507414 A CA2507414 A CA 2507414A CA 2507414 A1 CA2507414 A1 CA 2507414A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- alkyl
- present
- subject
- reacting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 *C(C#C*)N(*)C[C@@]1N(*)c(cccc2)c2SC1 Chemical compound *C(C#C*)N(*)C[C@@]1N(*)c(cccc2)c2SC1 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30154002A | 2002-11-21 | 2002-11-21 | |
| US10/301,540 | 2002-11-21 | ||
| PCT/US2003/037592 WO2004047756A2 (en) | 2002-11-21 | 2003-11-20 | Propargyl-trifluoromethoxy-amino-benzothiazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2507414A1 true CA2507414A1 (en) | 2004-06-10 |
Family
ID=32392394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002507414A Abandoned CA2507414A1 (en) | 2002-11-21 | 2003-11-20 | Propargyl-trifluoromethoxy-amino-benzothiazole derivatives |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1569641A2 (is) |
| JP (1) | JP2006507350A (is) |
| KR (1) | KR20050083951A (is) |
| CN (1) | CN1741802A (is) |
| AU (1) | AU2003295898A1 (is) |
| BR (1) | BR0315704A (is) |
| CA (1) | CA2507414A1 (is) |
| IS (1) | IS7906A (is) |
| MX (1) | MXPA05005414A (is) |
| NO (1) | NO20052979L (is) |
| RU (1) | RU2005119307A (is) |
| WO (1) | WO2004047756A2 (is) |
| ZA (1) | ZA200504988B (is) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012050971A2 (en) * | 2010-09-29 | 2012-04-19 | Teva Pharmaceutical Industries Ltd. | Propargyl-trifluoromethoxy-aminobenzothiazole derivatives, their preparation and use |
| CN103340859A (zh) * | 2013-06-04 | 2013-10-09 | 中国科学院昆明动物研究所 | 侧脑室mpp+给药建立非人灵长类帕金森病动物模型的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59112978A (ja) * | 1982-12-21 | 1984-06-29 | Shionogi & Co Ltd | プロピニルアミノチアゾ−ル誘導体 |
-
2003
- 2003-11-20 CA CA002507414A patent/CA2507414A1/en not_active Abandoned
- 2003-11-20 RU RU2005119307/04A patent/RU2005119307A/ru not_active Application Discontinuation
- 2003-11-20 MX MXPA05005414A patent/MXPA05005414A/es not_active Application Discontinuation
- 2003-11-20 EP EP03787112A patent/EP1569641A2/en not_active Withdrawn
- 2003-11-20 KR KR1020057009216A patent/KR20050083951A/ko not_active Application Discontinuation
- 2003-11-20 JP JP2004555702A patent/JP2006507350A/ja active Pending
- 2003-11-20 BR BR0315704-0A patent/BR0315704A/pt not_active Application Discontinuation
- 2003-11-20 WO PCT/US2003/037592 patent/WO2004047756A2/en not_active Application Discontinuation
- 2003-11-20 CN CNA2003801090823A patent/CN1741802A/zh active Pending
- 2003-11-20 ZA ZA200504988A patent/ZA200504988B/en unknown
- 2003-11-20 AU AU2003295898A patent/AU2003295898A1/en not_active Abandoned
-
2005
- 2005-06-17 NO NO20052979A patent/NO20052979L/no not_active Application Discontinuation
- 2005-06-22 IS IS7906A patent/IS7906A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1741802A (zh) | 2006-03-01 |
| EP1569641A2 (en) | 2005-09-07 |
| RU2005119307A (ru) | 2006-01-27 |
| AU2003295898A1 (en) | 2004-06-18 |
| JP2006507350A (ja) | 2006-03-02 |
| WO2004047756A2 (en) | 2004-06-10 |
| MXPA05005414A (es) | 2006-05-25 |
| WO2004047756A3 (en) | 2004-07-08 |
| NO20052979L (no) | 2005-08-19 |
| NO20052979D0 (no) | 2005-06-17 |
| IS7906A (is) | 2005-06-22 |
| BR0315704A (pt) | 2005-09-06 |
| KR20050083951A (ko) | 2005-08-26 |
| ZA200504988B (en) | 2006-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230041335A1 (en) | Compositions and methods of treating retinal disease | |
| JP4796219B2 (ja) | 神経保護剤としてのプラミペキソールの使用 | |
| US20060205796A1 (en) | Method for treating pain or pruritis by administering opinoid receptor agonist comprising 2-phenylbenzothiazoling derivative | |
| CA2220024C (en) | Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents | |
| JP2010095550A (ja) | キノリン誘導体 | |
| CA2507414A1 (en) | Propargyl-trifluoromethoxy-amino-benzothiazole derivatives | |
| US20040176430A1 (en) | Propargyl-trifluoromethoxy-amino-benzothiazole derivatives | |
| JPH01193263A (ja) | Ｎ−（１−チエニルシクロアルキル）アルケニルアミン類 | |
| JP5100025B2 (ja) | プロスタグランジンＦ２α誘導体を有効成分として含む網膜神経細胞保護剤 | |
| US6187801B1 (en) | Polycyclic thiazole systems, processes for their preparation and pharmaceuticals comprising these compounds | |
| EP0143461B1 (en) | Rhodanine derivative, process for preparing the same and pharmaceutical composition containing the same | |
| WO2005084205A2 (en) | Diamino thiazoloindan derivatives and their use | |
| US11590158B2 (en) | Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using same | |
| WO2006050148A2 (en) | Propargyl trifluoromethoxy aminobenzimidazole derivatives | |
| CA1241327A (en) | Rhodanine derivative, process for preparing the same and pharmaceutical composition containing the same | |
| WO1999064396A1 (en) | Substituted 1-aryl-3-benzylaminopyrrolidine: dopamine receptor subtype specific ligands | |
| US20040072825A1 (en) | 2-(2-(4-((2r)-2-methyl-3-(10h-phenothiazin-10-yl)propyl)-1-piperazinyl)-ethoxy) ethanol, process for the preparation thereof, pharmaceutical compositions containing said compound and therapeutic uses thereof | |
| CA2096012A1 (en) | Intraocular pressure lowering heterocyclic compounds | |
| AU713581C (en) | Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents | |
| CA2359470A1 (en) | Novel 1,2-diphenyl-2-propen-1-one derivatives | |
| WO2006080287A1 (ja) | ２－アゾリルイミノ－１，３－チアジン誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |